Company Filing History:
Years Active: 1990
Title: Angelika Birkmann: Innovator in Recombinant DNA Technology
Introduction
Angelika Birkmann is a notable inventor based in Munich, Germany. She has made significant contributions to the field of biotechnology, particularly in the area of recombinant DNA technology. Her work has implications for gene expression and has the potential to advance various applications in genetic engineering.
Latest Patents
Angelika Birkmann holds a patent for "DNA for the repressible and inducible expression of foreign genes." This invention provides a recombinant DNA that contains a specific consensus sequence and a promoter with the DNA sequence GGN.sub.10 GC. The patent outlines a process for isolating this recombinant DNA by identifying a DNA sequence from a gene bank of a microorganism. This microorganism has a gene that is repressible by oxygen and inducible by formate under anaerobic conditions. The recombinant gene can be utilized for the inducible and repressible expression of a foreign gene, allowing for precise control over gene activity.
Career Highlights
Angelika Birkmann is currently employed at Boehringer Mannheim GmbH, where she continues to work on innovative projects in biotechnology. Her expertise in recombinant DNA technology has positioned her as a valuable asset in her field.
Collaborations
One of her notable collaborators is August Bock, with whom she has worked on various projects related to genetic engineering and biotechnology.
Conclusion
Angelika Birkmann's contributions to recombinant DNA technology exemplify her innovative spirit and dedication to advancing the field of biotechnology. Her patent on gene expression mechanisms highlights the potential for future applications in genetic research and development.